Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
QuintilesIMS
Baxter
Deloitte
Express Scripts
Fuji
US Army
Harvard Business School
Teva

Generated: May 21, 2018

DrugPatentWatch Database Preview

Claims for Patent: 8,946,207

« Back to Dashboard

Summary for Patent: 8,946,207
Title:Processes for preparing 3-benzazepines
Abstract: The present invention provides processes and intermediates for the preparation of 3-benzazepines and salts thereof which can be useful as serotonin (5-HT) receptor agonists for the treatment of, for example, central nervous system disorders such as obesity.
Inventor(s): Wolgast; Beverly L. (San Diego, CA), Gilson, III; Charles A. (San Diego, CA), Aytes; Shelley (San Diego, CA), Estrada; Scott A. (La Jolla, CA), Sengupta; Dipanjan (San Diego, CA), Smith; Brian (San Diego, CA), Rey; Max (Wallisellen, CH), Weigl; Ulrich (Hilzingen, DE)
Assignee: Arena Pharmaceuticals, Inc. (San Diego, CA)
Application Number:13/619,773
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,946,207
Patent Claims: 1. A composition comprising: a hydrochloric acid salt of a compound of Formula Va and a hydrochloric acid salt of a compound of Formula Vb, wherein the compound of Formula Va and the compound of Formula Vb have the structures, respectively, of ##STR00059## wherein R.sup.1 is H, R.sup.2 is Me, R.sup.3 is H, R.sup.4 is Cl, R.sup.5 is H, R.sup.6 is H, R.sup.8a is H, and R.sup.8b is H, and wherein the composition is enriched in the hydrochloric acid salt of the compound of Formula Vb.

2. The composition of claim 1, wherein the hydrochloric acid salt of the compound of Formula Vb is present in an enantiomeric excess of greater than about 80%.

3. The composition of claim 1, wherein the hydrochloric acid salt of the compound of Formula Vb is present in an enantiomeric excess of greater than about 90%.

4. The composition of claim 1, wherein the hydrochloric acid salt of the compound of Formula Vb is present in an enantiomeric excess of greater than about 95%.

5. The composition of claim 1, wherein the hydrochloric acid salt of the compound of Formula Vb is present in an enantiomeric excess of greater than about 98%.

6. The composition of claim 1, wherein the hydrochloric acid salt of the compound of Formula Vb is present in an enantiomeric excess of greater than about 99%.

7. The composition of claim 1, wherein the composition further comprises acetone.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Julphar
McKesson
Covington
Harvard Business School
QuintilesIMS
Teva
Johnson and Johnson
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.